SEC Form 4 · accession 0001140361-17-015116
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary P Scharmett
Director
Period of report
Apr 4, 2017
Accepted (ET)
Apr 6, 2017 · 1:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | Apr 4, 2017 | A | 10,000 | $0.00 | A | 230,718 | D | |
| Common Stock, par value $0.001 | Apr 4, 2017 | A | 17,364 | $0.55 | A | 248,082 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F4,F5 | $0.55 | Apr 4, 2017 | A | 10,000 | A | — | Apr 4, 2027 | Common Stock par value $0.001 | 10,000 | 10,000 | D |
Explanation of responses
- F1Grant of stock award under 2016 Director Equity Incentive Plan.
- F2Pursuant to the company's Amended and Restated Director Stock Purchase Plan, the reporting person has elected to receive a fully vested stock award for shares of the company's common stock in lieu of cash payment of director fees otherwise payable to the reporting person. The number of shares of common stock awarded represents the quotient of i) the director fees payable to the reporting person divided by (ii) $0.55, representing the average of the high and low trading prices reported on the NYSE MKT on April 4, 2017.
- F3The stock option was granted under the 2016 Director Equity Incentive Plan.
- F4The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE MKT) of the common stock on the grant date.
- F5The stock option vests on the first anniversary of the grant date.